Active Not RecruitingNCT05657301
Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration
PHASE1 · 25 planned enrolment
- Countries listed
- 1
- Registry update
- December 31, 2025
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–2 of 2. Every record below meets all the filters shown above.
PHASE1 · 25 planned enrolment
PHASE1 · PHASE2 · 42 planned enrolment